Pharmacological effect of BM-593, a novel sulfonylurea acting as thromboxane A2 receptor antagonist and thromboxane synthase inhibitor on human platelets and isolated smooth muscles

Research output: Contribution in Book/Catalog/Report/Conference proceedingConference contribution

Original languageEnglish
Title of host publicationAbstract Book-XVèmes Journées Franco-Belges de Pharmacochimie
EditorsPresses Universitaires, de Namur
Pages78
Publication statusPublished - 2001

Cite this